[
  {
    "name": "Acumen Pharmaceuticals — SEC Filings",
    "category": "ABOS",
    "type": "sec",
    "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001576885&output=atom",
    "enabled": true,
    "cik": "0001576885"
  },
  {
    "name": "ALX Oncology — SEC Filings",
    "category": "ALXO",
    "type": "sec",
    "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001810182&output=atom",
    "enabled": true,
    "cik": "0001810182"
  },
  {
    "name": "Amgen — SEC Filings",
    "category": "AMGN",
    "type": "sec",
    "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000318154&output=atom",
    "enabled": true,
    "cik": "0000318154"
  },
  {
    "name": "Regeneron — SEC Filings",
    "category": "REGN",
    "type": "sec",
    "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589&output=atom",
    "enabled": true,
    "cik": "0000872589"
  },
  {
    "name": "Jasper Therapeutics — SEC Filings",
    "category": "JSPR",
    "type": "sec",
    "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001788028&output=atom",
    "enabled": true,
    "cik": "0001788028"
  },
  {
    "name": "Acumen Pharmaceuticals — Clinical Trials",
    "category": "ABOS",
    "type": "clinical_trial",
    "url": "https://clinicaltrials.gov/api/v2/studies",
    "enabled": true,
    "company_terms": ["Acumen Pharmaceuticals", "ABOS", "ACU193", "sabirnetug"]
  },
  {
    "name": "ALX Oncology — Clinical Trials",
    "category": "ALXO",
    "type": "clinical_trial",
    "url": "https://clinicaltrials.gov/api/v2/studies",
    "enabled": true,
    "company_terms": ["ALX Oncology", "ALXO", "evorpacept", "ALX148"]
  },
  {
    "name": "Amgen — Clinical Trials",
    "category": "AMGN",
    "type": "clinical_trial",
    "url": "https://clinicaltrials.gov/api/v2/studies",
    "enabled": true,
    "company_terms": ["Amgen", "AMGN", "AMG", "sotorasib", "lumakras", "tezepelumab"]
  },
  {
    "name": "Regeneron — Clinical Trials",
    "category": "REGN",
    "type": "clinical_trial",
    "url": "https://clinicaltrials.gov/api/v2/studies",
    "enabled": true,
    "company_terms": ["Regeneron", "REGN", "dupilumab", "dupixent", "eylea", "aflibercept"]
  },
  {
    "name": "Jasper Therapeutics — Clinical Trials",
    "category": "JSPR",
    "type": "clinical_trial",
    "url": "https://clinicaltrials.gov/api/v2/studies",
    "enabled": true,
    "company_terms": ["Jasper Therapeutics", "JSPR", "JSP191", "lenzilumab"]
  },
  {
    "name": "Acumen Pharmaceuticals — Press Releases",
    "category": "ABOS",
    "type": "rss",
    "url": "https://www.globenewswire.com/RSS/company/9134?symbol=ABOS",
    "enabled": true
  },
  {
    "name": "ALX Oncology — News Releases",
    "category": "ALXO",
    "type": "rss",
    "url": "https://ir.alxoncology.com/rss/news-releases",
    "enabled": true
  },
  {
    "name": "Regeneron — Press Releases",
    "category": "REGN",
    "type": "rss",
    "url": "https://www.globenewswire.com/RSS/company/5679",
    "enabled": true
  },
  {
    "name": "Jasper Therapeutics — News Releases",
    "category": "JSPR",
    "type": "html",
    "url": "https://ir.jaspertherapeutics.com/press-releases",
    "enabled": true
  },
  {
    "name": "Amgen — PR Newswire Releases",
    "category": "AMGN",
    "type": "html",
    "url": "https://www.prnewswire.com/news-releases/news-releases-list/?searchTerms=Amgen",
    "enabled": true
  },
  {
    "name": "FDA Press Releases",
    "category": "Industry",
    "type": "fda",
    "url": "https://www.fda.gov/about-fda/contact-fda/stay-informed/rss-feeds/press-releases/rss.xml",
    "enabled": true,
    "keywords": ["drug", "approval", "biotech", "pharmaceutical", "therapeutic"]
  },
  {
    "name": "FDA Drug Approvals and Safety",
    "category": "Industry",
    "type": "fda",
    "url": "https://www.fda.gov/drugs/drug-safety-and-availability/rss.xml",
    "enabled": true,
    "keywords": ["approval", "drug", "safety", "warning"]
  },
  {
    "name": "EMA News & Press Releases",
    "category": "Industry",
    "type": "ema",
    "url": "https://www.ema.europa.eu/en/news.xml",
    "enabled": true,
    "keywords": ["medicine", "approval", "recommendation", "chmp"]
  },
  {
    "name": "Gene & Cell Therapy — ASGCT News",
    "category": "Industry",
    "type": "rss",
    "url": "https://www.asgct.org/rss/news",
    "enabled": true,
    "keywords": ["gene therapy", "cell therapy", "car-t", "crispr"]
  },
  {
    "name": "GLP-1 & Obesity — Reuters Health",
    "category": "Industry",
    "type": "rss",
    "url": "https://www.reuters.com/finance/healthcare/feed",
    "enabled": true,
    "keywords": ["glp-1", "obesity", "diabetes", "semaglutide", "tirzepatide"]
  },
  {
    "name": "BioPharma Dive — Latest News",
    "category": "Industry",
    "type": "rss",
    "url": "https://www.biopharmadive.com/feeds/news/",
    "enabled": true,
    "keywords": ["biotech", "pharmaceutical", "clinical trial"]
  },
  {
    "name": "FierceBiotech — Latest News",
    "category": "Industry",
    "type": "rss",
    "url": "https://www.fiercebiotech.com/rss/xml",
    "enabled": true,
    "keywords": ["biotech", "clinical", "fda", "approval"]
  },
  {
    "name": "Novo Nordisk News",
    "category": "Industry",
    "type": "rss",
    "url": "https://www.novonordisk.com/bin/rss/news.xml",
    "enabled": true,
    "keywords": ["glp-1", "diabetes", "obesity", "semaglutide"]
  },
  {
    "name": "Eli Lilly News",
    "category": "Industry",
    "type": "rss",
    "url": "https://investor.lilly.com/rss/news-releases",
    "enabled": true,
    "keywords": ["diabetes", "obesity", "tirzepatide", "mounjaro"]
  }
]
